Beacon Pointe Advisors, LLC Adma Biologics, Inc. Transaction History

Beacon Pointe Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$4.4 - $6.74 $46,873 - $71,801	10,653 New	10,653 $70,000
Q1 2023 May 12, 2023	SELL	$3.01 - $3.87 $135 - $174	-45 Reduced 0.3%	14,915 $49,000
Q3 2022 Nov 09, 2022	BUY	$2.03 - $2.86 $30,368 - $42,785	14,960 New	14,960 $36,000
Q2 2022 Aug 11, 2022	SELL	$1.43 - $2.2 $33,590 - $51,678	-23,490 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$1.28 - $1.83 $5,708 - $8,161	-4,460 Reduced 15.96%	23,490 $43,000
Q4 2021 Feb 14, 2022	BUY	$1.09 - $1.66 $30,465 - $46,397	27,950 New	27,950 $39,000

326

190M

917K

91.6K

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $3.31B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

Get notified when there are updates to the investment portfolio of Beacon Pointe Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Beacon Pointe Advisors, LLC with notifications on news.